Gibson Christopher sold RXRX
August 11, 2025 · Form 4 insider transaction
Gibson Christopher sold 10,000 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeG: Gift
Transaction dateAugust 11, 2025
Filing dateAugust 13, 2025
Shares owned after994,619
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.; Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person